We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Abrdn Smaller Companies Income Trust Plc | ASCI | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 238.00 | 00:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 238.00 | 238.00 |
| Industry Sector |
|---|
| EQUITY INVESTMENT INSTRUMENTS |
| Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
| 30/10/2023 | Interim | GBP | 0.1475 | 09/11/2023 | 10/11/2023 | 24/11/2023 |
| 14/09/2023 | Interim | GBP | 0.026 | 28/09/2023 | 29/09/2023 | 27/10/2023 |
| 14/06/2023 | Interim | GBP | 0.026 | 29/06/2023 | 30/06/2023 | 28/07/2023 |
| 03/03/2023 | Interim | GBP | 0.026 | 30/03/2023 | 31/03/2023 | 28/04/2023 |
| 01/12/2022 | Interim | GBP | 0.026 | 05/01/2023 | 06/01/2023 | 27/01/2023 |
| 07/09/2022 | Interim | GBP | 0.024 | 06/10/2022 | 07/10/2022 | 28/10/2022 |
| 13/06/2022 | Interim | GBP | 0.024 | 30/06/2022 | 01/07/2022 | 22/07/2022 |
| 04/03/2022 | Interim | GBP | 0.024 | 07/04/2022 | 08/04/2022 | 25/04/2022 |
| 19/11/2021 | Interim | GBP | 0.024 | 06/01/2022 | 07/01/2022 | 28/01/2022 |
| 07/09/2021 | Interim | GBP | 0.0215 | 07/10/2021 | 08/10/2021 | 29/10/2021 |
| 22/06/2021 | Interim | GBP | 0.0215 | 01/07/2021 | 02/07/2021 | 23/07/2021 |
| 22/03/2021 | Interim | GBP | 0.0215 | 01/04/2021 | 06/04/2021 | 23/04/2021 |
| 21/12/2020 | Interim | GBP | 0.0206 | 31/12/2020 | 04/01/2021 | 29/01/2021 |
| 29/09/2020 | Interim | GBP | 0.0206 | 08/10/2020 | 09/10/2020 | 30/10/2020 |
| 18/06/2020 | Interim | GBP | 0.0206 | 02/07/2020 | 03/07/2020 | 24/07/2020 |
| 26/03/2020 | Interim | GBP | 0.0206 | 02/04/2020 | 03/04/2020 | 24/04/2020 |
| Top Posts |
|---|
Posted at 27/11/2023 21:28 by dr biotech Its part of the process...On 30 October 2023 the Board announced that, subject to the passing of the resolutions at the First General Meeting, a Pre-liquidation Dividend of 14.75p per Ordinary share in respect of the year to 31 December 2023 would be paid to Shareholders (on the register as at close of business on 10 November 2023) on 24 November 2023. This condition has been satisfied. The Ordinary Shares will be disabled for settlement in CREST from 6:00 p.m. on 24 November 2023 and trading will be suspended from 7.30 a.m. on 27 November 2023. Following the reclassification of the Ordinary Shares on 30 November 2023, the Reclassified Shares will be suspended from listing at 7.30 a.m. on 1 December 2023. The full text of the ordinary and special resolutions of the First General Meeting are set out in the Notice of First General Meeting, contained in the Company's circular to Shareholders dated 17 October 2023 (the "Circular"). |
Posted at 09/11/2023 08:50 by citytilidie Looking at the disastrous share prices performance of both since the merger was announced, it would appear to me that Aberdeen now realise that they may have made a dreadful mistake. If they thought that the 2 funds were too small then they should have simply liquidated them. ASCI shareholders would have received in the region of £2.80 instead of the current price of £2.30, and Shire holders would have received £2.50 instead of the current price of £2.20.Aberdeen, trying to keep the 2 lots of funds under their own umbrella have ended up costing both lots of shareholders millions of pounds needlessly due to their own ineptitude, and I’m sure institutions holding these companies are not best pleased. I hope they remember this when it comes to the forthcoming vote, and whether to vote for or against it. |
Posted at 04/11/2023 15:14 by taylor20 My understanding is if opting for the cash option you will get NAV per share - 1.5%.So for example based on NAV on 03/11/2023 of £2.5647/share you will get 14.75p dividend (reducing NAV to £2.4172). You will then get a distribution of £2.381 per share. If going for the SHRS share option you will get the divi of 14.75p then £2.4172 used to buy SHRS shares based on 1.008 * NAV, again based on most recent NAV of £2.3919 price per share will be £2.411. So if you hold 1000 shares: You would receive £147.50 dividend. Cash option would receive: £2380.94 Share Option would receive (2417.20 / 2.411) 1002 SHRS shares, currently worth £2195.60 Obviously discount to NAV may change between now and the offer completing, but does not seem to be worth doing the share option, or maybe I'm missing something! |
Posted at 04/11/2023 10:58 by beaverfish hi,can anybody help?if i take the cash offer will it be the nav value or will it be the share price value approx ? or will it be nav/share value minus the dividend 14.75p ???Or if I elect to do nothing,will my 5800 shares roll over into "Shires"and still be worth approx what they are now thanks in advance |
Posted at 21/7/2023 12:33 by essentialinvestor IF the outcome of the strategic review is for ASCI to continue (in it's currentform_ we may be looking at a NAV discount moving to 20-25% type range?. That would be the ugly outcome. Trust wind up near NAV gives 13-14% upside, all else being equal. |
Posted at 13/2/2023 11:53 by dlp6666 Is it still worth 'taking a punt' on ASCI, given that the discount seems to have come in by c.13% this morning (so perhaps only a 6% uplift to NAV available on wind-up)?Or better to wait until things presumably 'settle back down' (the strategic review may be prolonged and not be so advantageous)? |
Posted at 13/2/2023 09:02 by davebowler For immediate release13 February 2023 abrdn Smaller Companies Income Trust plc ("the Company") Strategic Review The Company continues to deliver upon its investment objective of providing a high and growing dividend and capital growth from a portfolio invested principally in UK smaller companies and UK fixed income securities. However, the Company's shares have continued to trade at a material discount to their net asset value for a prolonged period of time and this, coupled with the Company being of a small scale, has created challenges in generating improved liquidity in the Company's shares and will also restrict the Company's ability to grow over time. Whilst the board of directors of the Company (the "Board") believes that the Company remains in a position to continue to generate attractive returns for all shareholders, the Board today announces that it intends to undertake a strategic review to consider the future of the Company. The strategic review will include consideration of a combination of the Company's assets with another suitable investment trust, possibly coupled with a cash exit. The Board will continue to update shareholders on the progress of the strategic review, as appropriate. There can be no certainty as to the outcome of the strategic review nor whether any potential transaction would be successfully completed. Enquiries: Dagmar Kershaw, Chair 0131 372 2200 Joe Winkley, Winterflood Securities |
Posted at 06/10/2022 18:03 by essentialinvestor Not saying otherwise, just an observation on their portfolio in a bear market and also some recent decisions.Watkin Jones a shocking recent buy, ASCI bought following..several very encouraging meetings with the management. XPP, why the hell did they not sell on the first sign of litigation concerns, particularly as the fund must have been very significantly in profit on that holding. |
Posted at 06/10/2022 15:06 by essentialinvestor That's my point, the reverse is the case in a bear market.I can buy IPU on a 15% discount, with a lot more liquidity than ASCI. ASCI NAV discount needs to be around 17% plus for me to add here. |
Posted at 22/7/2022 14:50 by orinocor There's been a big rally in the ftse250 shares this week. My MRC shares are up 10% but asci has hardly moved out the trough chart wise. I think the shares should be 275p or higher. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
